Alnylam ALNY

Latest articles

5d
Fortune
The 4 Best Biotech and Health Care Stocks to Buy for 2018Loncar and Bakri see huge opportunities for firms on the cusp of FDA approvals
Fortune / Posted 5 days ago
Loncar and Bakri see huge opportunities for firms on the cusp of FDA approvals in spaces like gene therapy. Bakri points to Alnylam Pharmaceuticals (alny), whose shares have risen an absurd 259% this year thanks to promising clinical trial results... Read more
6d
FOX Business
Why Alnylam Pharmaceuticals Rose 12.7% in NovemberWhat happened In response to the company sharing a slew of positive developmen
FOX Business / Posted 6 days ago
What happened In response to the company sharing a slew of positive developments with investors, shares of Alnylam Pharmaceuticals(NASDAQ: ALNY), a clinical-stage biotech focused on RNAi therapies, jumped 13% in November according to data from S&P... Read more
6d
FOX Business
Why Alnylam Pharmaceuticals Rose 12.7% in NovemberReading Below In response to the company sharing a slew of positive developmen
FOX Business / Posted 6 days ago
Reading Below In response to the company sharing a slew of positive developments with investors, shares of Alnylam Pharmaceuticals(NASDAQ: ALNY), a clinical-stage biotech focused on RNAi therapies, jumped 13% in November according... Read more
22d
Business Wire
U.S. Food and Drug Administration (FDA) Grants Alnylam Breakthrough Therapy Designation (BTD) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis with PolyneuropathyCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY)
Business Wire / Posted 22 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for patisiran, an... Read more
27d
FOX Business
Alnylam Pharmaceuticals, Inc.'s Pipeline Progresses, Approval NextEven though biotech Alnylam Pharmaceuticals(NASDAQ: ALNY) doesn't have any drug
FOX Business / Posted 27 days ago
Even though biotech Alnylam Pharmaceuticals(NASDAQ: ALNY) doesn't have any drugs on the market, it had a solid third quarter in terms of pipeline development, with a drug passing its phase 3 trial, joining two others that are already in phase 3... Read more
27d
FOX Business
Alnylam Pharmaceuticals, Inc.'s Pipeline Progresses, Approval NextEven though biotech Alnylam Pharmaceuticals(NASDAQ: ALNY) doesn't have any drug
FOX Business / Posted 27 days ago
Even though biotech Alnylam Pharmaceuticals(NASDAQ: ALNY) doesn't have any drugs on the market, it had a solid third quarter in terms of pipeline development, with a drug passing its phase 3 trial, joining two others that are already in phase 3... Read more
29d
Business Wire
Alnylam Pharmaceuticals Prices Public Offering of Common StockCAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY)
Business Wire / Posted 29 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the pricing of an underwritten registered public offering of 5,600,000 shares of its common stock at a public... Read more
8 related articles

In this news